טמסולין ישראל - עברית - Ministry of Health

טמסולין

rafa laboratories ltd - tamsulosin hydrochloride - modified release capsules - tamsulosin hydrochloride 0.4 mg - tamsulosin - tamsulosin - treatment of functional symptoms of benign prostatic hyperplasia (bph).

דנול 200 ישראל - עברית - Ministry of Health

דנול 200

sanofi - aventis israel ltd - danazol - קפסולות - danazol 200 mg - danazol

סאפנלו ישראל - עברית - Ministry of Health

סאפנלו

astrazeneca (israel) ltd - anifrolumab - תרכיז להכנת תמיסה לאינפוזיה - anifrolumab 150 mg/ml - anifrolumab

נקסיום טבליות 20 מג ישראל - עברית - Ministry of Health

נקסיום טבליות 20 מג

astrazeneca (israel) ltd - esomeprazole - טבליה - esomeprazole 20 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.

נקסיום טבליות  40 מג ישראל - עברית - Ministry of Health

נקסיום טבליות 40 מג

astrazeneca (israel) ltd - esomeprazole - טבליה - esomeprazole 40 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.

פלומיסט קואדריוואלנט ישראל - עברית - Ministry of Health

פלומיסט קואדריוואלנט

astrazeneca (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - ספריי לאף - b/phuket/3073/2013 (b/yamagata lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/darwin/9/2021 (h3n2)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 7 ±0.5 log10 ffu^a / 0.2 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - flumist quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses ad type b viruses contained in the vaccine. flumist quadrivalent is approved for use in persons 2 through 49 years of age.

נקסיום טבליות 20 מג ישראל - עברית - Ministry of Health

נקסיום טבליות 20 מג

astrazeneca (israel) ltd - esomeprazole - טבליה - esomeprazole 20 mg - esomeprazole

נקסיום טבליות 40 מג ישראל - עברית - Ministry of Health

נקסיום טבליות 40 מג

astrazeneca (israel) ltd - esomeprazole - טבליה - esomeprazole 40 mg - esomeprazole

לינפארזה 100 מג ישראל - עברית - Ministry of Health

לינפארזה 100 מג

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 100 mg - olaparib

לינפארזה 100 מג ישראל - עברית - Ministry of Health

לינפארזה 100 מג

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 100 mg - olaparib